for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Core Laboratories N.V.

CLB.N

Latest Trade

24.60USD

Change

1.11(+4.73%)

Volume

16,073

Today's Range

23.89

 - 

24.69

52 Week Range

21.94

 - 

49.15

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
23.49
Open
24.03
Volume
16,073
3M AVG Volume
11.64
Today's High
24.69
Today's Low
23.89
52 Week High
49.15
52 Week Low
21.94
Shares Out (MIL)
46.29
Market Cap (MIL)
1,087.34
Forward P/E
33.36
Dividend (Yield %)
0.17

Next Event

Q4 2021 Core Laboratories NV Earnings Release

Latest Developments

More

Core Lab Reports Q3 Results From Continuing Operations

Core Laboratories NV - QTRLY Revenue Of $118.7 Million, Up 3%

Core Lab Reports Qtrly Adjusted Earnings Per Share $0.15

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Industry

Oil Well Services & Equipment

Contact Info

Tower a, Level 9, Strawinskylaan 913

1077 XX

Netherlands

+31.24.203191

https://www.corelab.com/

Executive Leadership

Lawrence V. Bruno

Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer

Christopher S. Hill

Chief Financial Officer, Senior Vice President

Mark F. Elvig

General Counsel, Secretary

Martha Z. Carnes

Presiding Independent Lead Director

Gregory B. Barnett

Independent Member of the Supervisory Board

Key Stats

2.90 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.7K

2019

0.7K

2020

0.5K

2021(E)

0.5K
EPS (USD)

2018

2.280

2019

1.780

2020

0.790

2021(E)

0.704
Price To Earnings (TTM)
34.56
Price To Sales (TTM)
2.37
Price To Book (MRQ)
6.94
Price To Cash Flow (TTM)
21.60
Total Debt To Equity (MRQ)
120.38
LT Debt To Equity (MRQ)
120.38
Return on Investment (TTM)
6.95
Return on Equity (TTM)
5.33

Latest News

Latest News

U.S. RESEARCH ROUNDUP- Arco Platform, Qualcomm, Walt Disney

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arco Platform, Qualcomm and Workday, on Thursday. HIGHLIGHTS * Arco Platform Ltd : Credit Suisse cuts to neutral from outperform * Boston Beer Company Inc...

U.S. RESEARCH ROUNDUP- Arch Coal, Glacier Bancorp, IHS Markit

all Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arch Coal, Glacier Bancorp and IHS Markit on Monday. HIGHLIGHTS * Arch Coal Inc : Jefferies cuts to hold from buy * Alliance Data Systems Corp : Compass Point...

Greenlight's Einhorn tweaks portfolio, says CFO to leave

Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors on Wednesday he had made some changes to the fund's main portfolio, including selling Bayer <BAYGn.DE>, Mylan <MYL.O> and Perrigo <PRGO.N> last year.

Einhorn's Greenlight sells some positions, covers prominent shorts

Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors that he had made some changes to the portfolio, including selling Bayer <BAYGn.DE>, Mylan <MYL.O>and Perrigo <PRGO.N> last year.

Einhorn's Greenlight sells some positions, covers prominent shorts

Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors that he had made some changes to the portfolio, including selling Bayer, Mylan and Perrigo last year.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up